and its affiliates for which CASI has exclusive rights to the greater China market, consisting of EVOMELA (Melphalan for Injection), ZEVALIN (Ibritumomab Tiuxetan) and MARQIBO (
Vincristine Sulfate Liposome Injection) and (iv) a portfolio of FDA-approved and pending abbreviated new drug applications (ANDAs), including entecavir and tenofovir disoproxil fumarate (TDF) indicated for the treatment of hepatitis B virus.
and its affiliates for which CASI has exclusive rights to the greater China market, consisting of EVOMELA[R] (Melphalan for Injection), ZEVALIN[R] (Ibritumomab Tiuxetan) and MARQIBO[R] (
Vincristine Sulfate Liposome Injection); and (iv) a portfolio of FDA-approved and pending abbreviated new drug applications (ANDAs), including entecavir and tenofovir disoproxil fumarate (TDF) indicated for the treatment of hepatitis B virus.
has approved the company's Clinical Trial Application allowing for a registration clinical trial to evaluate the efficacy and safety of
vincristine sulfate Liposome injection, Marqibo.
Under the deal, Acrotech will acquire products including Fusilev (levoleucovorin), Folotyn (pralatrexate injection), Zevalin (ibritumomab tiuxetan), Marqibo (
vinCRIStine sulfate Liposome injection), Beleodaq (belinostat) for injection, Evomela (melphalan) for injection and Khapzory (levoleucovorin).
Under the sale, the seven US FDA-approved hematology/oncology products include: FUSILEV (levoleucovorin), FOLOTYN (pralatrexate injection), ZEVALIN (ibritumomab tiuxetan), MARQIBO (
vinCRIStine sulfate LIPOSOME injection), BELEODAQ (belinostat) for injection, EVOMELA (melphalan) for injection, and KHAPZORY (levoleucovorin).
In the third-line treatment 4 (22%) out of 18 patients were treated with ifosfamide-based regimen, 8 (44.4%) received one of CHOP-like regimens, 3 (16.6%) platinum-based regimen, while 2 (11.1%) received cyclophosphamide,
vincristine sulfate, adriamycin, dexamethasone (hyper CVAD).